Put Options Transactions Made in Q3 2023 in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during Q3 2023. The information is specifically focused on institutions that hold put options of CRISPR Therapeutics AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2023
Q3 2023
|
Gts Securities LLC
New York, NY |
BUY
|
PUT |
64.1KNew |
$2.91M - $3.78M
|
64.1K
$3.31M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
PUT |
41.9K+ 143.99% |
$1.9M - $2.47M
|
71K
$3.67M
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
PUT |
5.9K+ 13.72% |
$268K - $348K
|
48.9K
$2.52M
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
PUT |
4.3K+ 72.88% |
$195K - $254K
|
10.2K
$527K
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
PUT |
3.9K+ 9.56% |
$177K - $230K
|
44.7K
$2.31M
|
|
|
Nov 14, 2023
Q3 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
BUY
|
PUT |
200+ 0.44% |
$9.08K - $11.8K
|
45.2K
$2.33M
|
|
|
Nov 09, 2023
Q3 2023
|
Hap Trading, LLC
New York, NY |
SELL
|
PUT |
-200- 0.4% |
$9.08K - $11.8K
|
50.4K
$2.6M
|
|
|
Nov 14, 2023
Q3 2023
|
Capital Fund Management S.A.
Paris, I0 |
SELL
|
PUT |
-8.9K- 41.78% |
$404K - $525K
|
12.4K
$640K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-16.6K- 4.07% |
$753K - $979K
|
391K
$20.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-31.3K- 11.93% |
$1.42M - $1.85M
|
231K
$11.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
PUT |
-140K- 82.35% |
$6.35M - $8.26M
|
30K
$1.55M
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
PUT |
-198K- 98.98% |
$8.99M - $11.7M
|
2.04K
$105K
|